ペプチド合成の世界市場

世界のペプチド合成の市場規模は、2023年の901億米ドルから、予測期間中は11.8%のCAGRで推移し、2028年末には1,575億米ドルの規模に成長すると予測されています。

世界のペプチド合成の市場規模は、2023年の283億米ドルから、同期間中は12.8%のCAGRで推移し、2028年末には516億米ドルに達すると予測されています。世界の生物活性ペプチドの市場規模は、2023年の183億米ドルから、CAGR 12.6%で推移し、2028年末には330億米ドルに達すると予測されています。

当レポートでは、世界のペプチド合成の市場を調査し、市場概要、法規制環境、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

市場区分：

ペプチドタイプ別

• ペプチド合成
• 抗菌ペプチド
• ホルモンペプチド
• 生物活性ペプチド
• コラーゲンペプチド
• その他

用途別

• 癌
• 糖尿病
• 神経
• その他（心臓病、希少疾患など）
• ペプチド治療薬
• 化粧品
• 栄養補助食品
• その他（創薬、医療用画像診断）

合成タイプ別：

• 固相
• 溶液相
• ハイブリッド相

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• ペプチド治療
• ペプチドの重要性
• ペプチド合成
• ペプチド治療の動向

第3章 市場力学

• 市場促進要因
• 概要
• 慢性疾患の発症率の上昇
• ペプチドドラッグデリバリーの発展
• バイオテクノロジー支出の増加
• 感染症と慢性疾患の増加
• 市場抑制要因
• ペプチド合成生産における持続可能性の課題
• 市場機会
• 経口ペプチド治療薬
• 新興国における機会

第4章 ペプチド合成と治療薬製造のための新技術

• 水性媒体におけるSPPSの進歩
• 化学合成
• ペプチドドラッグデリバリー
• 新開発事例：企業別
• Nissan Chemical Corp.
• Gyros Protein Technologies AB

第5章 市場分析：各種区分別

• 分類の内訳
• 世界のペプチド合成市場：ペプチドタイプ別
• ペプチド合成
• 抗菌ペプチド
• ホルモンペプチド
• 生物活性ペプチド
• コラーゲンペプチド
• その他
• 世界のペプチド合成市場：用途別
• ペプチド治療
• 化粧品
• 栄養補助食品
• その他
• 世界のペプチド合成市場：合成タイプ別
• 固相
• 溶液相
• ハイブリッド相
• 世界のペプチド合成市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情勢

• 主要企業
• 戦略分析
• M&A分析
• M&A取引
• 成長するバイオテクノロジー新興企業
• Neumora Therapeutics Inc.
• Altos Labs
• Affini-T Therapeutics
• Capstan Therapeutics
• Septerna Inc.

第7章 ペプチド合成産業における持続可能性：ESGの観点

• ペプチド治療薬メーカーにおけるESGの重要性
• ペプチド治療薬メーカーのESG実践
• BCCによる視点

第8章 付録

• 調査手法
• 参考文献
• 企業プロファイル
• ABBOTT
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• BRISTOL MYERS SQUIBB CO.
• B. BRAUN SE
• LILLY
• MERCK & CO. INC.
• MODERNA INC.
• NOVARTIS AG
• NOVO NORDISK A/S
• SANOFI
• TEVA PHARMACEUTICAL INDUSTRIES LTD.

List of Tables

• Summary Table : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 1 : Pros and Cons of Liquid Phase and Solid Phase Synthesis
• Table 2 : Global Cancer Incidence
• Table 3 : Emerging Trends in Peptide Synthesis Technologies
• Table 4 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 5 : Global Market for Synthetic Type Peptides, by Region, Through 2028
• Table 6 : Global Market for Antimicrobial Type Peptides, by Region, Through 2028
• Table 7 : FDA-Approved Antimicrobial Peptide Drugs
• Table 8 : Global Market for Hormonal Peptides, by Region, Through 2028
• Table 9 : Global Market for Bioactive Peptides, by Region, Through 2028
• Table 10 : Global Market for Collagen Peptides, by Region, Through 2028
• Table 11 : Global Market for Other Peptides, by Region, Through 2028
• Table 12 : Global Market for Peptide Synthesis, by Application, Through 2028
• Table 13 : Global Market for Peptide Therapeutics, by Region, Through 2028
• Table 14 : Peptide-based Drugs Approved by FDA in 2021
• Table 15 : Best-Selling Peptide Therapeutics, 1982-2021
• Table 16 : Global Market for Cancer Applications in Peptide Therapeutics, by Region, Through 2028
• Table 17 : Approval of Peptide Agents Used for Cancer Therapy, 2019-2022
• Table 18 : Global Market for Diabetes Applications in Peptide Therapeutics, by Region, Through 2028
• Table 19 : Global Market for Neurology Applications in Peptide Therapeutics, by Region, Through 2028
• Table 20 : Global Market for Other Applications in Peptide Therapeutics, by Region, Through 2028
• Table 21 : Global Market for Cosmetics Applications in Peptide Synthesis, by Region, Through 2028
• Table 22 : Global Market for Nutraceutical Applications in Peptide Synthesis, by Region, Through 2028
• Table 23 : Global Market for Other Applications in Peptide Synthesis, by Region, Through 2028
• Table 24 : Global Market for Peptide Synthesis, by Synthesis Type, Through 2028
• Table 25 : Global Market for Solid-phase Synthesis, by Region, Through 2028
• Table 26 : Global Market for Solution-phase Synthesis, by Region, Through 2028
• Table 27 : Global Market for Hybrid-phase Synthesis, by Region, Through 2028
• Table 28 : Global Market for Peptide Synthesis, by Region, Through 2028
• Table 29 : North American Market for Peptide Synthesis, by Country, Through 2028
• Table 30 : Protein Subunit Vaccines, in Clinical Phases, 2021-2022
• Table 31 : European Market for Peptide Synthesis, by Country, Through 2028
• Table 32 : Products and Services in Nordic Countries, 2020-2023
• Table 33 : Asia-Pacific Market for Peptide Synthesis, by Country, Through 2028
• Table 34 : Japanese Market Statistics
• Table 35 : RoW Market for Peptide Synthesis, by Country, Through 2028
• Table 36 : Role of ESG in Environmental Performance
• Table 37 : Role of ESG in Social Performance
• Table 38 : Role of ESG in Governance Performance
• Table 39 : ESG Rankings for Major Peptide Therapeutics Companies*
• Table 40 : Abbott: Company Snapshot
• Table 41 : Abbott: Financial Performance, FY 2022 and 2023
• Table 42 : Abbott: Product Portfolio
• Table 43 : Abbott: Recent Developments, 2022
• Table 44 : AbbVie Inc.: Company Snapshot
• Table 45 : AbbVie Inc.: Financial Performance, FY 2022 and 2023
• Table 46 : AbbVie Inc.: Product Portfolio
• Table 47 : AbbVie Inc.: Recent Developments, 2022
• Table 48 : Amgen Inc.: Company Snapshot
• Table 49 : Amgen Inc.: Financial Performance, FY 2022 and 2023
• Table 50 : Amgen Inc.: Product Portfolio
• Table 51 : Amgen Inc.: Recent Developments, 2023
• Table 52 : AstraZeneca: Company Snapshot
• Table 53 : AstraZeneca: Financial Performance, FY 2022 and 2023
• Table 54 : AstraZeneca: Product Portfolio
• Table 55 : AstraZeneca: Recent Developments, 2024
• Table 56 : Boehringer Ingelheim International GmbH: Company Snapshot
• Table 57 : Boehringer Ingelheim International: Financial Performance, FY 2021 and 2022
• Table 58 : Boehringer Ingelheim International: Product Portfolio
• Table 59 : Boehringer Ingelheim International: Recent Developments, 2023
• Table 60 : Bristol Myers Squibb Co.: Company Snapshot
• Table 61 : Bristol Myers Squibb Co.: Financial Performance, FY 2022 and 2023
• Table 62 : Bristol Myers Squibb Co.: Product Portfolio
• Table 63 : Bristol Myers Squibb Co.: Recent Developments, 2022
• Table 64 : B. Braun SE: Company Snapshot
• Table 65 : B. Braun SE: Financial Performance, FY 2021 and 2022
• Table 66 : B. Braun SE: Product Portfolio
• Table 67 : B. Braun SE: Recent Developments, 2022
• Table 68 : Lilly: Company Snapshot
• Table 69 : Lilly: Financial Performance, FY 2022 and 2023
• Table 70 : Lilly: Product Portfolio
• Table 71 : Lilly: Recent Developments, 2022
• Table 72 : Merck & Co. Inc.: Company Snapshot
• Table 73 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
• Table 74 : Merck & Co. Inc.: Product Portfolio
• Table 75 : Merck & Co. Inc.: Recent Developments, 2021
• Table 76 : Moderna Inc.: Company Snapshot
• Table 77 : Moderna Inc.: Financial Performance, FY 2022 and 2023
• Table 78 : Moderna Inc.: Product Portfolio
• Table 79 : Moderna Inc.: Recent Developments, 2022
• Table 80 : Novartis AG: Company Snapshot
• Table 81 : Novartis AG: Financial Performance, FY 2022 and 2023
• Table 82 : Novartis AG: Product Portfolio
• Table 83 : Novartis AG: Recent Developments, 2023
• Table 84 : Novo Nordisk A/S: Company Snapshot
• Table 85 : Novo Nordisk A/S: Financial Performance, FY 2022 and 2023
• Table 86 : Novo Nordisk A/S: Product Portfolio
• Table 87 : Novo Nordisk A/S: Recent Developments, 2024
• Table 88 : Sanofi: Company Snapshot
• Table 89 : Sanofi: Financial Performance, FY 2022 and 2023
• Table 90 : Sanofi: Product Portfolio
• Table 91 : Sanofi: Recent Developments, 2022
• Table 92 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
• Table 93 : Teva Pharmaceutical: Financial Performance, FY 2022 and 2023
• Table 94 : Teva Pharmaceutical: Product Portfolio
• Table 95 : Teva Pharmaceutical: Recent Developments, 2024

List of Figures

• Summary Figure : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 1 : Trends in Peptide Therapeutics Manufacturing
• Figure 2 : Global Market for Peptide Synthesis: Market Dynamics
• Figure 3 : India's Biotechnology Sectoral Thrust
• Figure 4 : Global Projected Incidence of Diabetes, Patients Age 20-79, 2010 and 2030
• Figure 5 : Global Infectious Disease Outbreaks, 2020 to 2022
• Figure 6 : Global Infectious Disease Outbreak, 2022
• Figure 7 : Snapshot: Key Trends in Peptide Drugs and Therapeutics Technologies
• Figure 8 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 9 : Global Market Shares of Peptide Synthesis, by Application, 2022
• Figure 10 : Global Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 11 : Global Market Shares of Peptide Synthesis, by Region, 2022
• Figure 12 : North American Market Shares of Peptide Synthesis, by Application, 2022
• Figure 13 : North American Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 14 : North American Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 15 : North American Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 16 : North American Market Shares of Peptide Synthesis, by Country, 2022
• Figure 17 : European Market Shares of Peptide Synthesis, by Application, 2022
• Figure 18 : European Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 19 : European Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 20 : European Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 21 : European Market Shares of Peptide Synthesis, by Country, 2022
• Figure 22 : Asia-Pacific Market Shares of Peptide Synthesis, by Application, 2022
• Figure 23 : Asia-Pacific Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 24 : Asia-Pacific Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 25 : Asia-Pacific Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 26 : Asia-Pacific Market Shares of Peptide Synthesis, by Country, 2022
• Figure 27 : RoW Market Shares of Peptide Synthesis, by Application, 2022
• Figure 28 : RoW Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 29 : RoW Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 30 : RoW Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 31 : RoW Market Shares of Peptide Synthesis, by Country/Region, 2022
• Figure 32 : Leading Manufacturers' Shares of the Global Market for Peptide Synthesis, 2022
• Figure 33 : Snapshot: Key ESG Trends in Peptide Therapeutics Industry
• Figure 34 : Abbott: Revenue Shares, by Business Unit, FY 2023
• Figure 35 : Abbott: Revenue Shares, by Country/Region, FY 2023
• Figure 36 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 37 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 38 : Amgen Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 39 : Amgen Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 40 : AstraZeneca: Revenue Shares, by Business Unit, FY 2023
• Figure 41 : AstraZeneca: Revenue Shares, by Country/Region, FY 2023
• Figure 42 : Boehringer Ingelheim International: Revenue Shares, by Business Unit, FY 2022
• Figure 43 : Boehringer Ingelheim International: Revenue Shares, by Country/Region, FY 2022
• Figure 44 : Bristol Myers Squibb Co.: Revenue Shares, by Business Unit, FY 2023
• Figure 45 : Bristol Myers Squibb Co.: Revenue Shares, by Country/Region, FY 2023
• Figure 46 : B. Braun SE: Revenue Shares, by Business Unit, FY 2022
• Figure 47 : B. Braun SE: Revenue Shares, by Country/Region, FY 2022
• Figure 48 : Lilly: Revenue Shares, by Business Unit, FY 2023
• Figure 49 : Lilly: Revenue Shares, by Country/Region, FY 2023
• Figure 50 : Merck & Co. Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 51 : Merck & Co. Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 52 : Moderna Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 53 : Novartis AG: Revenue Shares, by Business Unit, FY 2023
• Figure 54 : Novartis AG: Revenue Shares, by Country/Region, FY 2023
• Figure 55 : Novo Nordisk A/S: Revenue Shares, by Business Unit, FY 2023
• Figure 56 : Novo Nordisk A/S: Revenue Shares, by Country/Region, FY 2023
• Figure 57 : Sanofi: Revenue Shares, by Business Unit, FY 2023
• Figure 58 : Sanofi: Revenue Shares, by Country/Region, 2023
• Figure 59 : Teva Pharmaceutical: Revenue Shares by Business Unit, FY 2023
• Figure 60 : Teva Pharmaceutical: Revenue Shares, by Country/Region, FY 2023

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

The global market for synthetic peptides is expected to grow from $28.3 billion in 2023 and projected to reach $51.6 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.8% during the forecast period of 2023 to 2028.

The global market for bioactive peptides is expected to grow from $18.3 billion in 2023 and projected to reach $33.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Report Scope

The report provides a detailed summary of the peptide synthesis market, with a focus on peptide therapeutics; a competitive landscape; and company profiles that include revenue, product portfolio and news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period.

The report will enable key players, other strategists and start-ups to make informed decisions about the production, marketing and licensing of goods and services. Organizations, exporters and distributors should find the information about market development and trends useful. The segments of the market provided in the report are peptide type, applications and synthesis type. Regional market analysis is provided for all segments, and country-level analysis in some cases. Key developments and ESG information for the companies is provided based on the market.

The market is divided into segments and by application/industry as follows:

By peptide types:

• Synthetic peptides.
• Antimicrobial peptides.
• Hormonal peptides.
• Bioactive peptides.
• Collagen peptides.
• Others.

By application:

• Cancer.
• Diabetes.
• Neurology.
• Others (cardiology, rare diseases, etc.).
• Peptide therapeutics.
• Cosmetics.
• Nutraceuticals.
• Others (drug discovery, medical imaging).

By synthesis type:

• Solid-phase.
• Solution-phase.
• Hybrid-phase.

For each of these areas, current products in the market are identified, measuring the market size and identifying potential market drivers. Forecasts for 2028 are attained by analyzing the current competitors' market shares for the base year of 2022. A top-down approach was also followed to determine peptide synthesis market shares in 2022 by consulting secondary and primary sources.

By geographic region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of World. The markets in countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries are analyzed. For market estimates, data is provided for 2022 as the base year, with estimates for 2023 and forecast values for 2028.

Report Includes

• 63 data tables and 56 additional tables
• An overview of the global market for peptide synthesis
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue forecast, and a corresponding market share analysis by product type, synthesis area, application, end-user, and region
• Facts and figures pertaining to major market dynamics, technological trends, latest developments in peptide production, pipeline drugs (manufactured using peptides), and future prospects
• Discussion of sustainability trends and factors, with emphasis on consumer attitudes, companies' ESG scores, the future of ESG, case studies and the ESG practices of companies
• Overview of the major vendors along with an analysis of the industry structure, including company market shares, recent M&A activity and venture funding outlook
• Competitive intelligence on the leading market players, including their product developments, business strategies, key financials and segmental revenues
• Profiles of the leading global players, including Novo Nordisk A/S., AbbVie Inc., Lilly, Novartis Ag, AstraZeneca, and Teva Pharmaceutical

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Peptide Therapeutics
• Importance of Peptides
• Peptide Synthesis
• Trends in Peptide Therapeutics

Chapter 3 Market Dynamics

• Market Drivers
• Overview
• Rising Incidence of Chronic Diseases
• Developments in Peptide Drug Delivery
• Increase in Biotech Spending
• Increase in Infectious and Chronic Diseases
• Market Restraints
• Issues in Sustainability in Synthetic Peptide Production
• Market Opportunities
• Oral Peptide Therapeutics
• Opportunities in Emerging Nations

Chapter 4 Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing

• Introduction
• Advances in SPPS in Aqueous Media
• Chemical Synthesis
• Peptide Drug Delivery
• Examples of New Developments, by Company
• Nissan Chemical Corp.
• Gyros Protein Technologies AB

Chapter 5 Market Analysis, by Segment

• Segmentation Breakdown
• Peptide Synthesis by Peptide Type
• Global Market for Peptide Synthesis, by Peptide Type
• Synthetic Peptides
• Antimicrobial Peptides
• Hormonal Peptides
• Bioactive Peptides
• Collagen Peptides
• Other Products
• Global Market for Peptide Synthesis, by Application
• Peptide Therapeutics
• Cosmetics
• Nutraceuticals
• Other Types of Applications
• Peptide Synthesis by Synthesis Type
• Global Market for Peptide Synthesis by Synthesis Type
• Solid-phase
• Solution-phase
• Hybrid-phase
• Peptide Synthesis by Region
• Regional Breakdown
• Global Market for Peptide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Landscape

• Top Players
• Strategic Analysis
• M&A Analysis
• M&A Deals in 2020-2023
• Flourishing Biotech Startups (2023)
• Neumora Therapeutics Inc.
• Altos Labs
• Affini-T Therapeutics
• Capstan Therapeutics
• Septerna Inc.

Chapter 7 Sustainability in the Peptide Synthesis Industry: An ESG Perspective

• Importance of ESG among Peptide Therapeutics Manufacturers
• ESG Practices of Peptide Therapeutics Manufacturers
• BCC Research Viewpoint

Chapter 8 Appendix

• Research Methodology
• References
• Company Profiles
• ABBOTT
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• BRISTOL MYERS SQUIBB CO.
• B. BRAUN SE
• LILLY
• MERCK & CO. INC.
• MODERNA INC.
• NOVARTIS AG
• NOVO NORDISK A/S
• SANOFI
• TEVA PHARMACEUTICAL INDUSTRIES LTD.